Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer. (Record no. 24146968)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02115 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516231811.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201505s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1748-717X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1186/1748-717X-9-190 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kerner, Gerald S M A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150511 |
245 00 - TITLE STATEMENT | |
Title | Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Radiation oncology (London, England) |
Date of publication, distribution, etc. | Aug 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 190 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carboplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemoradiotherapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cisplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Induction Chemotherapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiation-Sensitizing Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiotherapy, Conformal |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vinblastine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Dullemen, Leon F A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wiegman, Erwin M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Widder, Joachim |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blokzijl, Edwin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Driever, Ellen M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Putten, John W G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liesker, Jeroen J W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Renkema, Tineke E J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pieterman, Remge M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mertens, Marc J F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hiltermann, Thijo J N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Groen, Harry J M |
773 0# - HOST ITEM ENTRY | |
Title | Radiation oncology (London, England) |
Related parts | vol. 9 |
-- | p. 190 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1186/1748-717X-9-190">https://doi.org/10.1186/1748-717X-9-190</a> |
Public note | Available from publisher's website |
No items available.